Search

Patients with inflammatory bowel disease (IBD) who required treatment with biologic therapies and were enrolled in a financial assistance program were less likely to need surgery after starting medication than those not enrolled in a program, a study by UT Southwestern researchers found.

For patients with estrogen receptor (ER)-positive breast cancer, development of the so-called Y537S mutation signals that their disease has taken an aggressive course and may become resistant to endocrine therapy.

The National Academy of Medicine announced the election of two UT Southwestern Medical Center faculty members – Lora Hooper, Ph.D., Chair of Immunology, and Zhijian “James” Chen, Ph.D., Professor of Molecular Biology and Director of the Center for Inflammation Research.

New research has uncovered a surprising role for so-called “jumping” genes that have traditionally been considered a source of genetic mutations responsible for a number of human diseases.

In southern Dallas County, UT Southwestern researchers are creating groundbreaking initiatives that are giving access to postpartum care to thousands of new mothers. The bold new study, Improving Maternal Postpartum Access to Care through Telemedicine (IMPACT), is exploring how virtual care and smartphone-based education can transform maternal health outcomes.

Even though repeated hits to the head are common in professional sports, the long-term effects of concussions are still poorly understood.

Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections

UT Southwestern Medical Center scientists have identified the first two cases of the B.1.617.2 (Indian origin) variant of COVID-19 infection in North Texas using next-generation sequencing technologies along with targeted PCR testing.

Lowering iron content in fat cells prevented mice fed a high-fat diet from gaining excess weight and developing associated health problems by limiting the amount of lipids absorbed by the intestines

Researchers at the Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered a new metabolic vulnerability in a highly aggressive form of non-small cell lung cancer (NSCLC).